MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine
|
By LabMedica International staff writers Posted on 26 Sep 2024 |
|
At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements. Professional forums and their accompanying stage programs will delve into health IT, medical technology trends, healthcare policy, and laboratory medicine. Among the highlights is the MEDICA LABMED FORUM, known for its informative lectures and expert panel discussions, which has become a key feature of the MEDICA program. Around 6,000 companies have secured their spots at MEDICA 2024 and COMPAMED 2024, the concurrent supplier trade fair. Last year, both events together attracted a total of 83,000 visitors.
This year, the focus is on massive digitalization, networking, big data applications, and artificial intelligence (AI), collectively referred to as "Lab 4.0." On November 11, the opening day of MEDICA 2024, the MEDICA LABMED FORUM will address the hot topic of digitalization and AI. The morning session will concentrate on the shortage of skilled personnel, a pressing issue in laboratory medicine. Panelists will explore how automation and digitalization could help resolve this crisis. The afternoon session will shift to AI and big data tools that are either currently available or in development. Discussions will cover image recognition through deep learning, now standard for automated leucogram analysis, and the developmental state of machine learning for handling the vast multivariate data sets in laboratory diagnostics. A key question will be whether large language models can clarify complex lab findings and whether AI is making us smarter or dumber.
On the second day, discussions will focus on developments in laboratory medicine regarding cardiovascular diseases and cancer, the leading causes of mortality in the Western world. The cardiology section will highlight congenital heart defects, which are increasingly surgically correctable in childhood and are becoming more prominent in adult medicine due to extended life expectancy. Speakers will provide a clinical perspective and demonstrate the potential of machine learning in modern data evaluation. The afternoon session will cover highly sensitive cancer diagnostics using blood, known as “liquid biopsy,” which is revolutionizing oncology by allowing closer monitoring of tumor progression than conventional tissue biopsies. The session will also explore new techniques like analyzing methylation profiles for early detection of hereditary cancer forms and single-cell analysis using microfluidics.
On Young Scientists' Day, the next generation of researchers will present their perspectives on the future of laboratory medicine, offering insights into the latest advancements and challenges. Topics will include wearables for continuous diagnostic monitoring and the ongoing shortage of skilled personnel. The afternoon will feature discussions on personalized therapy based on individual laboratory parameters, the integration of laboratory and imaging diagnostics, and the role of AI in these fields.
The forum’s final day traditionally focuses on diagnostic research institutes and companies looking to introduce new applications in laboratory medicine. The theme for 2024 will center on aging, with sessions examining pathophysiology, diagnostics, and treatment. Topics will include the genetic and epigenetic factors influencing biological aging, protein misfolding as a basis for neurodegenerative diseases like Alzheimer's and Parkinson's, and the role of gut microbiota in strokes. As the forum’s "grand finale," discussions will address theories and practical approaches to slowing the aging process, such as anti-aging drugs, the effects of anti-inflammatory agents, environmental influences on aging in the central nervous system, and methods for repairing nervous system lesions.
Related Links:
MEDICA
Latest Industry News
- Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
- Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
- New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
- Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
- Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration
- Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
- Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
- Research Collaboration to Advance AI-Enhanced, Real-Time Optical Imaging in Lung Cancer Biopsy
- CACLP 2025 Unites Global Innovators in IVD Industry
- Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
- ABL Signs Know-How License and Transfer Agreement for Siemens’ Fast Track Diagnostics PCR Portfolio
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- New Partnership Revolutionizes Analyses of Biological Samples
- Medlab Middle East Looks to The Future of Laboratories
- Medix Biochemica Acquires German Immunoassay Solutions Developer Candor Bioscience
- bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more
Molecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
